| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 08/08/2000 | US6100272 Tetracyclic spiro compounds as 5HT1B receptor antagonists |
| 08/08/2000 | US6100037 Polynucleotide encoding a cyclic nucleotide phosphodiesterase having a specific amino acid sequence; diagnosis, treatment, and prevention of cancer and immune disorders; anticarcinogenic/antidiabetic/antiarthritic agents |
| 08/03/2000 | WO2000044770A1 Substituted phenethylamine derivatives |
| 08/03/2000 | WO2000044710A2 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 08/03/2000 | WO2000044400A1 Treatment for diabetes |
| 08/03/2000 | WO2000044350A1 Transnasal transport/immunisation with highly adaptable carriers |
| 08/03/2000 | WO2000006185A3 Methods of using lanreotide, a somatostatin analogue |
| 08/03/2000 | CA2360643A1 Transnasal transport/immunisation with highly adaptable carriers |
| 08/03/2000 | CA2359030A1 Substituted phenethylamine derivatives |
| 08/03/2000 | CA2356855A1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 08/03/2000 | CA2326741A1 The use of gastrin in the treatment of diabetes |
| 08/02/2000 | EP1023323A1 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 08/02/2000 | EP1023322A1 Novel npy family member |
| 08/02/2000 | EP1023263A1 Novel vitamin d analogues |
| 08/02/2000 | EP0885229B1 Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon |
| 08/02/2000 | EP0613373B1 Risedronate delayed-release compositions |
| 08/02/2000 | CN1261534A Medicinal composition containing naphthyl compound |
| 08/02/2000 | CN1055008C Chinese herbal medicine for curing thyreoidism |
| 08/02/2000 | CN1054985C Medicine for curing hyperplasia of mammary glands and its preparing method |
| 08/02/2000 | CN1054977C Chinese medicinal preparation for curing hypothyroidism and its preparing method |
| 08/01/2000 | US6096787 Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones |
| 08/01/2000 | US6096781 2-phenyl-1-benzothiophene derivatives are useful for treatment of osteoporosis and hyperlipemia |
| 08/01/2000 | US6096735 Benzoheterocyclic derivatives |
| 08/01/2000 | US6096513 Amino acid sequences; for screening agonists and antagonists; for analgesics |
| 08/01/2000 | US6096318 Antigenically modified HCG polypeptides |
| 08/01/2000 | CA2209925C 5,6-diaryl-5,6,7,8-tetrahydronaphthalenes and their analogs as estrogen agonists/antagonists |
| 08/01/2000 | CA2151618C Derivatives of benzoylecgonine, ecgonine and ecgonidine as medicines |
| 08/01/2000 | CA2006322C Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides |
| 07/27/2000 | WO2000043553A1 Identifying, monitoring, and treating women for breast precancer or cancer |
| 07/27/2000 | WO2000043495A2 33 human secreted proteins |
| 07/27/2000 | WO2000043408A2 Steroid sulfatase inhibitors and methods for making and using the same |
| 07/27/2000 | WO2000043401A1 Boron steroid mimics and pharmaceutical compositions |
| 07/27/2000 | WO2000043387A1 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them |
| 07/27/2000 | WO2000043378A1 New morpholinobenzamide salts |
| 07/27/2000 | WO2000043038A1 Methods and devices for delivery of agents to breast milk ducts |
| 07/27/2000 | WO2000043029A1 Uses of vascular endothelial growth factor in the treatment of erectile dysfunction |
| 07/27/2000 | WO2000043016A1 DICARBA-closo-DODECABORANE DERIVATIVES |
| 07/27/2000 | WO2000043008A1 Anti-androgens and methods for treating disease |
| 07/27/2000 | WO2000042998A1 Multiparticulate bisoprolol formulation |
| 07/27/2000 | WO2000042841A1 Methods for identifying, treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer |
| 07/27/2000 | CA2361272A1 33 human secreted proteins |
| 07/27/2000 | CA2361168A1 Steroid sulfatase inhibitors and methods for making and using the same |
| 07/27/2000 | CA2361123A1 Methods for identifying, treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer |
| 07/27/2000 | CA2361122A1 Methods and devices for delivery of agents to breast milk ducts |
| 07/27/2000 | CA2361064A1 Boron steroid mimics and pharmaceutical compositions |
| 07/27/2000 | CA2360058A1 Uses of vascular endothelial growth factor in the treatment of erectile dysfunction |
| 07/27/2000 | CA2359709A1 Multiparticulate bisoprolol formulation |
| 07/27/2000 | CA2359107A1 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them |
| 07/27/2000 | CA2359105A1 New morpholinobenzamide salts |
| 07/27/2000 | CA2358971A1 Identifying, monitoring, and treating women for breast precancer or cancer |
| 07/26/2000 | EP1022274A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use |
| 07/26/2000 | EP1022272A1 Substituted fused heterocyclic compounds |
| 07/26/2000 | EP1021193A1 THERAPEUTICALLY EFFECTIVE 1$g(a), 25-DIHYDROXYVITAMIN D 3? ANALOGS |
| 07/26/2000 | EP1021191A2 Tightening and/or reducing the size of body parts containing fat cells |
| 07/26/2000 | EP1021190A1 Novel amide derivatives |
| 07/26/2000 | EP1021175A1 Compounds and methods for therapeutic intervention in preventing diabetic complications |
| 07/26/2000 | CN1261281A Peptide parathyroid hormone analogs |
| 07/26/2000 | CN1054856C New 19-nor steroids having phenoxyalkylsulphonemide or phenoxyalkylsulphonylurea chain in position llbeta, preparation process and intermediates, use as medicaments and pharmaceutical |
| 07/25/2000 | US6093838 Amines substituted with a dihydro-benzofuranyl or with a dihydro-isobenzofuranyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 07/25/2000 | US6093719 Method and pharmaceutical composition for regulating lipid concentration |
| 07/25/2000 | US6093421 Maca and antler for augmenting testosterone levels |
| 07/20/2000 | WO2000042211A1 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith |
| 07/20/2000 | WO2000042175A1 Methods for making proteins containing free cysteine residues |
| 07/20/2000 | WO2000042172A2 Human homologues of proteins regulated by circadian rhythms |
| 07/20/2000 | WO2000042031A2 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 07/20/2000 | WO2000042003A1 Benzenesulfonamide derivatives and their use as mek inhibitors |
| 07/20/2000 | WO2000042002A1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors |
| 07/20/2000 | WO2000041704A1 Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
| 07/20/2000 | WO2000041682A1 Lipophilic microparticles containing a protein drug or antigen and formulation comprising same |
| 07/20/2000 | WO2000041548A2 Methods for glucagon suppression |
| 07/20/2000 | WO2000041546A2 Novel exendin agonist formulations and methods of administration thereof |
| 07/20/2000 | WO2000015176A3 Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities |
| 07/20/2000 | CA2360588A1 Human homologues of proteins regulated by circadian rhythms |
| 07/20/2000 | CA2359798A1 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith |
| 07/20/2000 | CA2359562A1 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 07/20/2000 | CA2359345A1 Methods for making proteins containing free cysteine residues |
| 07/20/2000 | CA2356706A1 Novel exendin agonist formulations and methods of administration thereof |
| 07/20/2000 | CA2349832A1 Benzenesulfonamide derivatives and their use as mek inhibitors |
| 07/20/2000 | CA2349467A1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors |
| 07/19/2000 | EP1019402A1 Polymorphic forms of a growth hormone secretagogue |
| 07/19/2000 | EP1019071A2 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods |
| 07/19/2000 | EP1019057A1 A method of preventing or treating estrogen-dependent diseases and disorders |
| 07/19/2000 | EP0641355B1 Use of sulphamate derivatives as steroid sulphatase inhibitors |
| 07/19/2000 | CN1054543C Composition for sustained and controlled release of medicamentous substances and process for preparing same |
| 07/19/2000 | CN1054537C Medicine for treating centripetalis obesity |
| 07/18/2000 | US6090944 Alkanoic acid derivatives as αv integrin receptor antagonists |
| 07/18/2000 | US6090843 Benzothiophenes compounds which have useful pharmaceutical activity |
| 07/18/2000 | US6090782 Contacting hematopoietic cells with a stem cell proliferation inhibition amount of a peptide or polypeptide having specific amino acid sequence |
| 07/18/2000 | US6090779 Use of hemoglobin to treat septic shock |
| 07/18/2000 | CA2117610C Indole derivatives as steroid 5 alpha-reductase inhibitors |
| 07/13/2000 | WO2000040733A1 Human cyclic nucleotide pdes |
| 07/13/2000 | WO2000040613A1 Insulin-like growth factor (igf) i mutant variants |
| 07/13/2000 | WO2000040612A1 Insulin-like growth factor (igf) i mutant variants |
| 07/13/2000 | WO2000040259A1 Prolonged release microsphere encapsulating luteinizing hormone-releasing hormone analogues and method for preparing the same |
| 07/13/2000 | WO2000006534A9 Compounds and compositions for delivering active agents |
| 07/13/2000 | CA2358495A1 Prolonged release microsphere encapsulating luteinizing hormone-releasing hormone analogues and method for preparing the same |
| 07/13/2000 | CA2357146A1 Human cyclic nucleotide pdes |
| 07/12/2000 | EP1017672A1 New npy antagonists |
| 07/12/2000 | EP1017410A1 Compounds useful for the modulation of processes mediated by nuclear hormone receptors, methods for the identification and use of such compounds |
| 07/12/2000 | EP1017395A1 Method for treating premenstrual or late luteal phase syndrome |